These data are supportive of a central role of CELA1 in AAT-deficient emphysema and suggest that selective CELA1 neutralization could be an alternative for purified AAT replacement therapy in AAT-deficient emphysema. Here, SERPINA1 is linked to pulmonary emphysema.